LBA2 POD1UM-303/InterAACT 2: Phase III Study of Retifanlimab with Carboplatin-Paclitaxel (C-P) in Patients (pts) with Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal (SCAC) Not Previously Treated with Systemic Chemotherapy (Chemo)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要